المؤلفون: Akbari, Abolfazl^1,2 (AUTHOR), Hadizadeh, Shiva^2,3 (AUTHOR), Heidary, Leida^4,5 (AUTHOR)

المصدر: Journal of Diabetes Research. 3/18/2024, Vol. 2024, p1-14. 14p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CAROTID intima-media thickness, *DAPAGLIFLOZIN, *CLINICAL trials

المؤلفون: Gavigan, Colleen, Donner, Thomas

المصدر: Journal of Diabetes Research; 8/8/2023, p1-6, 6p

مصطلحات موضوعية: TYPE 2 diabetes, WEIGHT loss, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, INSULIN therapy

المؤلفون: Song, Rui¹ (AUTHOR), Qian, Hang¹ (AUTHOR), Wang, Yunlian¹ (AUTHOR), Li, Qingmei¹ (AUTHOR), Li, Dongfeng¹ (AUTHOR), Chen, Jishun¹ (AUTHOR), Yang, Jingning² (AUTHOR), Zhong, Jixin³ (AUTHOR), Yang, Handong¹ (AUTHOR), Min, Xinwen¹ (AUTHOR), Xu, Hao¹ (AUTHOR), Yang, Yong¹ (AUTHOR), Chen, Jun^1,2,4,5 (AUTHOR)

المصدر: Journal of Diabetes Research. 4/8/2022, p1-8. 8p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CARDIOVASCULAR system, *TYPE 2 diabetes, *BLOOD sugar

المؤلفون: Yaribeygi, Habib¹ (AUTHOR), Farrokhi, Farin Rashid² (AUTHOR), Abdalla, Mohammed Altigani³ (AUTHOR), Sathyapalan, Thozhukat³ (AUTHOR), Banach, Maciej⁴ (AUTHOR), Jamialahmadi, Tannaz^5,6 (AUTHOR), Sahebkar, Amirhossein^7,8,9 (AUTHOR)

المصدر: Journal of Diabetes Research. 6/30/2021, p1-10. 10p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *CARDIOLOGICAL manifestations of general diseases, *GLUCAGON-like peptide-1 agonists, *BLOOD pressure, *DIABETES complications, *INDUCED labor (Obstetrics)

المؤلفون: Sawada, Noritaka¹ (AUTHOR), Adachi, Kei¹ (AUTHOR), Nakamura, Nobuhisa² (AUTHOR), Miyabe, Megumi² (AUTHOR), Ito, Mizuho² (AUTHOR), Kobayashi, Shuichiro¹ (AUTHOR), Miyajima, Shin-ichi¹ (AUTHOR), Suzuki, Yuki¹ (AUTHOR), Kikuchi, Takeshi¹ (AUTHOR), Mizutani, Makoto³ (AUTHOR), Toriumi, Taku³ (AUTHOR), Honda, Masaki³ (AUTHOR), Mitani, Akio¹ (AUTHOR), Matsubara, Tatsuaki² (AUTHOR), Naruse, Keiko² (AUTHOR)

المصدر: Journal of Diabetes Research. 11/20/2020, p1-9. 9p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *LIRAGLUTIDE, *NITRIC-oxide synthases, *PERIODONTITIS, *PEOPLE with diabetes

المؤلفون: Liu, Yufang¹, Zhang, Xiaomei¹, Chai, Sanbao¹, Zhao, Xin¹, Ji, Linong²

المصدر: Journal of Diabetes Research. 7/16/2019, p1-10. 10p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *THERAPEUTICS, *FIXED effects model

المؤلفون: Babenko, Alina Yu.¹, Savitskaya, Daria A.¹, Kononova, Yulia A.¹, Trofimova, Aleksandra Yu.¹, Simanenkova, Anna V.¹, Vasilyeva, Elena Yu.¹, Shlyakhto, Evgeny V.¹

المصدر: Journal of Diabetes Research. 3/3/2019, p1-12. 12p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *GASTRIC inhibitory polypeptide, *WEIGHT loss, *METABOLIC regulation, *TYPE 2 diabetes

المؤلفون: Mohiuddin, Mohammad Sarif¹, Himeno, Tatsuhito¹, Inoue, Rieko¹, Miura-Yura, Emiri¹, Yamada, Yuichiro¹, Nakai-Shimoda, Hiromi¹, Asano, Saeko¹, Kato, Makoto¹, Motegi, Mikio¹, Kondo, Masaki¹, Seino, Yusuke², Tsunekawa, Shin¹, Kato, Yoshiro¹, Suzuki, Atsushi², Naruse, Keiko³, Kato, Koichi⁴, Nakamura, Jiro¹, Kamiya, Hideki¹

المصدر: Journal of Diabetes Research. 2/21/2019, p1-10. 10p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 agonists, *GLUCAGON-like peptide-1 receptor, *DORSAL root ganglia, *ZWITTERIONS, *PERIPHERAL nervous system, *CYCLIC adenylic acid, *INVECTIVE

المؤلفون: Ma, Xiaowei¹, Lu, Ran¹, Gu, Nan¹, Wei, Xiaowei¹, Bai, Ge¹, Zhang, Jianwei¹, Deng, Ruifen¹, Feng, Nan¹, Li, Jianping², Guo, Xiaohui¹

المصدر: Journal of Diabetes Research. 9/9/2018, p1-6. 6p.

مصطلحات موضوعية: *TYPE 2 diabetes, *GLUCAGON-like peptide-1 receptor, *CORONARY artery bypass, *SINGLE nucleotide polymorphisms, *CARDIOVASCULAR diseases

المؤلفون: del Olmo-Garcia, María Isabel^1,2,3, Merino-Torres, Juan Francisco^1,2,3

المصدر: Journal of Diabetes Research. 4/2/2018, p1-12. 12p.

مصطلحات موضوعية: *TYPE 2 diabetes complications, *GLUCAGON-like peptide-1 receptor, *CARDIOVASCULAR diseases risk factors, *GLYCEMIC control, CARDIOVASCULAR disease related mortality